Longevity Health Holdings(XAGE)
$0.110.00 (0.00%)
XAGE
Longevity Health Holdings financials statements
$0.11
At close:0.00 (0.00%)
Longevity Health Holdings (XAGE) Ratios
96 Followers
Longevity Health Holdings Ratios
XAGE's free cash flow for Q2 2026 was $-223.88K. For the 2026 fiscal year, XAGE's free cash flow was increased by $0.00 and operating cash flow was $-223.88K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.25 | 0.16 | 1.63 | 0.08 | 0.01 |
| Quick Ratio | 0.12 | 0.14 | 1.63 | 0.08 | 0.01 |
| Cash Ratio | 0.09 | 0.03 | 0.08 | 0.02 | 0.05 |
| Solvency Ratio | -0.81 | -1.64 | -0.39 | -0.22 | -0.20 |
| Operating Cash Flow Ratio | -0.42 | -0.75 | -0.22 | -0.47 | -0.07 |
| Short-Term Operating Cash Flow Coverage | -17.53 | -18.20 | -6.48 | -1.23 | -0.14 |
| Net Current Asset Value | $ -6.28M | $ -5.23M | $ 23.70M | $ -38.93M | $ -30.96M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.21 | 0.43 | 0.03 | 2.14 | 6.22 |
| Debt-to-Equity Ratio | -0.09 | -0.14 | 0.09 | -0.10 | -0.33 |
| Debt-to-Capital Ratio | -0.09 | -0.16 | 0.08 | -0.11 | -0.49 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| Financial Leverage Ratio | -0.40 | -0.31 | 2.58 | -0.05 | -0.05 |
| Debt Service Coverage Ratio | -32.05 | -35.86 | -6.98 | -0.78 | -0.01 |
| Interest Coverage Ratio | -390.23 | -101.98 | -5.87 | -1.47 | -0.19 |
| Debt to Market Cap | 0.37 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.30 | 0.03 | 0.15 | 0.38 | 0.62 |
| Net Debt to EBITDA | 0.03 | -0.05 | 0.05 | -0.71 | -102.14 |
| Profitability Margins | |||||
| Gross Profit Margin | 57.23% | 87.37% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | -358.15% | -21262.23% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | -346.91% | -20870.20% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | -371.58% | -9933.82% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | -359.11% | -21359.64% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | -361.00% | -20605.47% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -361.00% | -21166.31% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.53% | 96.47% | 95.31% | 100.00% | 1966.99% |
| EBT Per EBIT | 96.64% | 215.02% | 310.61% | 164.34% | 70.47% |
| Return on Assets (ROA) | -291.73% | -703.42% | -24.15% | -517.65% | -416.09% |
| Return on Equity (ROE) | 117.70% | 220.01% | -62.41% | 23.95% | 21.91% |
| Return on Capital Employed (ROCE) | 128.08% | 113.53% | -20.50% | 99.30% | 3.28% |
| Return on Invested Capital (ROIC) | 135.02% | 121.59% | -19.41% | 208.67% | 8.46% |
| Return on Tangible Assets | -293.60% | -712.92% | -24.16% | -526.29% | -425.16% |
| Earnings Yield | -1332.22% | -5.93% | -0.65% | -0.15% | -0.11% |
| Efficiency Ratios | |||||
| Receivables Turnover | 52.41 | 0.16 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.18 | 0.00 | 0.03 | 0.11 | 0.00 |
| Inventory Turnover | 0.85 | 0.06 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 4.76 | 0.10 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.81 | 0.03 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | -0.35 | 0.01 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -1568.90 | -224542.77 | -12920.24 | -3218.38 | 0.00 |
| Days of Sales Outstanding | 6.96 | 2219.20 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 429.69 | 6241.52 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 2005.56 | 233003.49 | 12920.24 | 3218.38 | 0.00 |
| Operating Cycle | 436.65 | 8460.72 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.93 | -0.21 | -0.40 | -0.17 | -0.06 |
| Free Cash Flow Per Share | -1.94 | -0.21 | -0.40 | -0.17 | -0.06 |
| Dividend Paid and CapEx Coverage Ratio | -234.04 | 0.00 | -273.98 | -478.60 | -161.81 |
| Capital Expenditure Coverage Ratio | -234.04 | 0.00 | -273.98 | -478.60 | -161.81 |
| Operating Cash Flow Coverage Ratio | -6.66 | -6.87 | -3.91 | -0.92 | -0.12 |
| Operating Cash Flow to Sales Ratio | -1.74 | -87.22 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -645.05% | -2.51% | -0.35% | -0.06% | -0.02% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.08 | -16.74 | -153.72 | -649.99 | -880.60 |
| Price-to-Sales (P/S) Ratio | 0.27 | 3477.45 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -0.09 | -37.13 | 95.93 | -155.68 | -192.90 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.16 | -39.87 | -283.37 | -1712.30 | -4818.28 |
| Price-to-Operating Cash Flow Ratio | -0.16 | -39.87 | -284.41 | -1715.88 | -4848.06 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 0.52 | -3.20 | -0.14 | 0.00 |
| Enterprise Value Multiple | -0.05 | -16.71 | -156.24 | -1163.51 | -65490.57 |
| Enterprise Value | 311.47K | 175.46M | 2.37B | 5.89B | 5.71B |
| EV to EBITDA | -0.05 | -16.71 | -156.24 | -1163.51 | -65490.57 |
| EV to Sales | 0.16 | 3487.02 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -0.09 | -39.98 | -283.28 | -1713.35 | -4825.81 |
| EV to Operating Cash Flow | -0.09 | -39.98 | -284.31 | -1716.93 | -4855.63 |
| Tangible Book Value Per Share | -3.41 | -0.23 | 1.19 | -1.91 | -1.50 |
| Shareholders’ Equity Per Share | -3.41 | -0.23 | 1.19 | -1.91 | -1.50 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 1.11 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -4.01 | -0.50 | -0.74 | -0.46 | -0.33 |
| Tax Burden | 1.01 | 0.96 | 0.95 | 1.00 | 19.67 |
| Interest Burden | 1.00 | 1.00 | 1.06 | 1.71 | 1.00 |
| Research & Development to Revenue | 0.41 | 20.95 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 3.83 | 77.60 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.36 | 16.44 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.48 | 0.37 | 0.54 | 0.38 | 0.18 |
Currency in USD

